Janux Therapeutics Inc (JANX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
996,529,000
EV to revenue ratio (TTM)
2.502
EV to ebitda
-33.8
Financial Performance
Revenue (TTM)
24,000,000
Gross profit (TTM)
-99,984,000
EBITDA
-141,654,000
Profitability
Operating margin (TTM)
-308.70%
Profit margin
0.00%
Return on assets (TTM)
-8.80%
Return on equity (TTM)
-10.70%
Per Share Metrics
Revenue per share (TTM)
0.38
EPS
-1.64
Diluted EPS (TTM)
-1.64
Book value
15.19
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
41.52
Price to book ratio (TTM)
1.088
Growth
Quarterly earnings growth (YoY)
2,178.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
14
Hold
1
Sell
0
Strong sell
1
Risk & Volatility
Beta
2.52